Volitionrx (VNRX) Share-based Compensation Growth (1y) (2012 - 2025)
Volitionrx (VNRX) Share-based Compensation Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | 59.09% |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | -30.44% |
| 10 | Volitionrx | 99,574.04 | -1.02 Mn | - | 1,807.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,807.77% |
| Jun 30, 2025 | -278.76% |
| Mar 31, 2025 | 14,641.15% |
| Dec 31, 2024 | -33.03% |
| Sep 30, 2024 | -39.86% |
| Jun 30, 2024 | -64.87% |
| Mar 31, 2024 | -99.56% |
| Dec 31, 2023 | -95.83% |
| Sep 30, 2023 | -15.82% |
| Jun 30, 2023 | -30.68% |
| Mar 31, 2023 | -24.19% |
| Dec 31, 2022 | 971.22% |
| Sep 30, 2022 | -16.82% |
| Jun 30, 2022 | 152.94% |
| Mar 31, 2022 | 64.77% |
| Dec 31, 2021 | 134.83% |
| Sep 30, 2021 | 79.22% |
| Jun 30, 2021 | -12.92% |
| Mar 31, 2021 | 235.63% |
| Dec 31, 2020 | -154.39% |